Work

Hyperpolarized 1-[13C]-Pyruvate Magnetic Resonance Imaging Detects an Early Metabolic Response to Immune Checkpoint Inhibitor Therapy in Prostate Cancer

Year: 2021

Type: article

Source: European Urology

DOI: 10.1016/j.eururo.2021.10.015

Authors: Ivan de Kouchkovsky, Hsin-Yu Chen, Michael A. Ohliger, Zhen J. Wang, Robert A. Bok, Jeremy W. Gordon, Peder E.Z. Larson, Mary Frost, Kimberly Okamoto, Matthew R. Cooperberg, John Kurhanewicz, Daniel B. Vigneron, Rahul Aggarwal

Institution: University of California, San Francisco

Language: English

Topic: Advanced NMR Techniques and Applications

Subfield: Spectroscopy

Field: Chemistry

Domain: Physical Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Cancer Institute, National Institute of Biomedical Imaging and Bioengineering

Awards: G2539072821, Co-Clinical Quantitative Imaging of Small Cell Neuroendocrine Prostate Cancer Using Hyperpolarized 13C MRI, Development and Translation of Hyperpolarized C-13 Prostate Cancer MRI Methods, Targeting Neuroendocrine Prostate Cancer Using Multi-Probe Hyperpolarized 13C MRI for Improved Treatment and Therapeutic Monitoring, G9000305863, Hyperpolarized MRI Technology Resource Center

OpenAlex ID: W3211864929

FWCI: 2.007

Cites: 5

Cited by: 28

Related to: 10